Clinical Oncology Week articles from September 2004

Clinical Oncology Week archives from September 2004

First patients enter pivotal phase II study of clofarabine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Bioenvision, Ltd., (BIV) has announced that the first adult patients have been dosed on a pivotal European phase II study to evaluate its lead leukemia compound, clofarabine, in the treatment of adults...

Immunotherapy of cancer reviewed.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Scientists review the immunotherapy of cancer in a recent issue of the Journal of Cancer Research and Clinical Oncology. "Until the end of the 19th century the possibility that a tumor could be...

Test for blood proteins detects ovarian cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Johns Hopkins Kimmel Cancer Center researchers have designed a blood test to detect ovarian cancer using three proteins found in common in the blood of women with the disease. Their preliminary...

Malignant melanomas increasing in teenagers and young adults.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The diagnosis of malignant melanomas is increasing in teenagers and young adults. "From data collected in a dermatopathology laboratory, the ratios between the numbers of specific cancers represent...

Rare localized relapse in bone marrow of extremities after ASCT for ALL reported.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A rare localized relapse in the bone marrow of the extremities after allogeneic peripheral blood stem cell transplantation for acute lymphoblastic leukemia is reported. "We report a patient with a...

Hair dye may be greater risk for adult acute leukemia than previously reported.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- According to research from the U.S., permanent hair dye use for 15 years or more may have a more significant impact on adult acute leukemia risk and other hematopoietic cancers than previously reported....

Gene-deleted oncolytic adenovirus vector activates cancer therapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Gene-deleted oncolytic adenovirus vector activates cancer therapy. "Viruses that replicate selectively in cancer cells constitute an exciting new class of anticancer agent. The conditionally...

University researcher awarded DOD grant to study prostate cancer drug.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Richard Valicenti, MD, associate professor of radiation oncology, Jefferson Medical College of Thomas Jefferson University and Jefferson's Kimmel Cancer Center in Philadelphia, has been awarded a grant...

Clever surgery turns an ankle into a "knee" after removing child's bone tumor.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- While limb-sparing surgery for bone cancer is becoming more common, very young children with bone cancer face significant challenges and have limited surgical options. A page in the August 19,...

Marijuana ingredient inhibits pathway required for brain tumor blood vessels.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cannabinoids, the active ingredients in marijuana, restrict the sprouting of blood vessels to brain tumors by inhibiting the expression of genes needed for the production of vascular endothelial growth...

Circulating tumor cells in blood indicate more aggressive disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Patients with advanced breast cancer who have more than five circulating tumor cells in the blood may have a more dangerous form of the disease, according to oncologists at the University of Texas M.D....

FDA approves early stage breast cancer drug.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pharmaceutical company Aventis has announced that it has won U.S. Food and Drug Administration approval of its drug Taxotere for treatment of women with early stage breast cancer. The FDA approval...

Race a factor in breast reconstruction after mastectomy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- African American women are significantly less likely to be treated with breast reconstruction after mastectomy than Caucasian, Asian, and Hispanic women, independent of age and clinical and...

Trastuzumab-related cardiotoxicity characterized.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Trastuzumab-associated cardiotoxicity has been characterized in breast cancer patients. "Trastuzumab (Herceptin) is a humanized monoclonal antibody that specifically targets HER2-positive breast...

New web site launched for online orders of NMP22 BladderChek Test.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Matritech, Inc., (MZT) announced the launch of its new web site at www.matritech.com to allow physicians to order Matritech's NMP22 BladderChek Test online. The web site will also provide updated...

ICTs exert opposing activities that can affect host defense systems.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Isothiocyanates (ITCs) affect tumor necrosis factor-alpha (TNF-alpha) production by J774A.1 (BALB/c macrophage) cells. According to a study from Japan, "The effects of ITCs on tumor TNF-alpha...

New cancer test speeds feedback on results of therapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Doctors using new technology can get fast feedback on whether treatments are working for breast cancer victims, a new study shows. The test that counts cancer cells in bloodstreams of patients with...

Period analysis provides up-to-date long-term cancer survival estimates.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers from Sweden reported that period analysis, in most cases, can provide up-to-date long-term cancer survival estimates. "The natural development of cancers as well as the measures to...

Collaboration to develop orally active chloride channel blocker cancer therapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- TopoTarget A/S has entered into a collaboration with NeuroSearch (NEUR.CO) to develop the NeuroSearch compound Endovion (NS3728), an orally active chloride channel blocker for the treatment of cancer....

Conversion of irinotecan to SN-38 in plasma characterized.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The conversion of irinotecan to SN-38 has been characterized in human plasma. "Irinotecan is an active cytotoxic agent for various cancers, and is converted to SN-38, its most active metabolite, by...

IVAD-related thrombotic complications characterized.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The adverse thrombotic effects associated with the use of implanted venous access devices (IVADs) have been characterized. IVADs are "routinely used in oncologic patients," scientists in France...

Pharmaceutical company announces third quarter financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- OSI Pharmaceuticals, Inc., (NASDAQ:OSIP) announced its financial results for the company's third quarter ended June 30, 2004. The company reported net losses for the third quarter and 9-month...

U.K. patient organizations recommends Glivec for inoperapeable tumors.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The National Institute for Clinical Excellence (NICE) concluded that Glivec (imatinib) should be prescribed in England and Wales, as a first-line option for all people with unresectable (inoperable)...

Pemetrexed (ALIMTA) is novel multitargeted antineoplastic agent.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pemetrexed (ALIMTA) is a novel multitargeted antineoplastic agent. "Pemetrexed (ALIMTA, LY231514, MTA) is a novel antimetabolite that inhibits at least three enzymes involved in the folate pathway....

AGUS coexisting with ASCUS signals clinically significant pathology.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Detection of atypical glandular cells of undetermined significance, especially along with atypical squamous cells of undetermined significance, by cervical cytologic screening is indicative to...

New DNA vaccine targets proteins expressed in cervical cancer cells.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Johns Hopkins Medical Institutions pathologists have developed a new DNA vaccine that targets proteins expressed in cervical cancer cells. Their work was described in the August 2004 issue of the...

Second Pap smear + HPV-DNA testing clarifies atypical glandular cell status.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Women in whom atypical glandular cells are detected via primary Pap smear may benefit from information gained from a second Pap test combined with human papillomavirus DNA testing, say researchers in...

New guideline does not recommend chemotherapy for stage II colon cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The American Society of Clinical Oncology (ASCO) has developed a set of recommendations to address whether patients who have had successful surgery for stage II colon cancer should be offered adjuvant...

Colorectal cancer risk greater in adenoma patients, Netherlands study shows.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- When compared to the general population, researchers from the Netherlands found that adenoma patients are at greater risk for colorectal cancer. "Colorectal cancer incidence after adenoma removal...

Stool-based DNA testing reviewed.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The utility of stool-based DNA testing for colorectal cancer has been reviewed. "Despite a variety of screening strategies and recent trends showing death rate stabilization, colorectal cancer still...

CMV prophylaxis following BMT has changed the natural history of the disease.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cytomegalovirus prophylaxis following bone marrow transplant has changed the natural history of the disease. "Cytomegalovirus (CMV) is a well-known cause of disease occurring after bone marrow...

Late CMV infection associated with SCT history of early CMV infection.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Late CMV infection is associated with donor lymphocyte infusion history of early CMV infection. "An increased incidence of late cytomegalovirus (CMV) infection has been reported during the last...

Pharmaceutical company licenses phase 2 hormone antagonist from biopharm entity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc. (SPPI) has acquired certain rights to D-63153, a fourth generation LHRH (luteinizing hormone releasing hormone, also known as GnRH or gonadotropin releasing hormone)...

Results abstract submitted from phase 2 trial of non-Hodgkin lymphoma drug.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc. (SPPI) announced that an abstract from the ongoing phase 2 trial evaluating elsamitrucin as a single agent for the treatment of relapsed or refractory non-Hodgkin lymphoma...

Does exposure to ammonia emissions lead to salivary gland cancer?
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the associations between ammonia, air pollution, socioeconomic status and access to medical care with incidence and mortality rates of salivary cancer in the South Carolina...

Tissue inhibitor of metalloproteinase 2 uses novel mechanisms to control tumors.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Tissue inhibitor of metalloproteinase 2 uses novel mechanisms to control tumors. "Solid tumors depend on angiogenesis for sustained growth. Tissue inhibitor of metalloproteinase 2 (TIMP-2) is an...

Local planners approve Vermont cancer center.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Local planners have given their approval for a proposed $8 million cancer center located in the former Ames department store building. The North Country Oncology Center is a joint venture between...

Oncology and cardiovascular products developer announces financial results.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Neoprobe Corporation (OTCBB:NEOP) announced consolidated operating results for the second quarter of 2004. Second quarter results included revenues of $1.5 million compared to $1.9 million for the...

Antiangiogenic agents are important adjuncts to conventional chemotherapy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Antiangiogenic agents are important adjuncts to conventional chemotherapy. According to recent research published in the European Journal of Cancer, "angiogenesis is an obligatory event for the...

Glivec recommended as first line management for gastrointestinal stromal tumors.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The National Institute for Clinical Excellence (NICE) has announced its final recommendations on the use of Glivec as first-line management of patients with KIT (CD117) positive unresectable and/or...

Patient-applied home therapy attractive option for treatment of genital warts.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Patient-applied home therapy is an attractive option for the treatment of genital warts. According to a study from North Ireland, "Genital warts are one of the most commonly reported sexually...

HAART improves outcome of HIV-associated plasmablastic lymphoma of oral cavity.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- "Plasmablastic lymphoma (PBL) is a recently described type of non-Hodgkin lymphoma (NHL) that occurs in up to 3% of patients with HIV infection. Although the clinical-pathological features of several...

Improved survival rates after re-irradiation, chemotherapy for recurring cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The diagnosis of head and neck cancer can be devastating to the patient and the family. What can be more disheartening is the discovery of a recurrence of the disease. Patients with locally...

Company to offer new women's cancer insurance.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Physicians Mutual Insurance Co. and a fund honoring civic leader Liz Karnes, who died in 2003 after a 12-year battle with cancer, have announced a partnership that will aid in the fight against cancers...

Raf-1 activation linked to pathogenesis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Raf-1 activation appears to be heavily involved in the pathogenesis of hepatocellular carcinoma. "Liver cirrhosis accompanies at least 70% of hepatocellular carcinomas world-wide," hepatologists in...

Chemo-radiation offers better post-treatment voice quality for laryngeal cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers find that laryngeal cancer patients treated with chemo-radiation have a similar survival rate and better speech after treatment than those who had their voice box removed. This finding...

Leukemia stem cells replenish supply of cancerous cells, research shows.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A handful of leukemia cells constantly replenish the supply of cancerous cells, according to new work by Stanford University School of Medicine researchers. These self-renewing cells, called cancer...

Hepatocellular carcinomas likely to increase in HIV/HBV coinfected patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hepatocellular carcinomas are likely to increase in HIV/HBV coinfected patients. According to recent research from the United States, "Infections with hepatitis B virus (HBV) and human...

Localized chemotherapy to the liver spares healthy tissue.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- In a retrospective study conducted at Mie University School of Medicine, Mie, Japan, 88 patients with advanced hepatocellular carcinoma (HCC) were treated with long-term chemotherapy infusion into the...

FDA approves lung cancer drug.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The Food and Drug Administration on Thursday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone...

Effects of anti-CD19 mAb on P-glycoprotein pump elucidated.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The molecular basis for an anti-CD19 antibody's sensitizing effects on lymphoma cells has been determined. Researchers in the United States "previously demonstrated that an anti-CD19 monoclonal...

MammoPad increases compression force, reduces discomfort during mammograms.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A newly published study in the peer-reviewed Breast Journal confirms that the MammoPad breast cushion greatly reduces the discomfort many women experience during mammograms even when compression force...

Automated robotic tools for real-time tumor targeting get FDA clearance.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Varian Medical Systems, Inc. (VAR) has received U.S. FDA 510(k) clearance for features added to the company's imaging system for Clinac and Trilogy medical linear accelerators (linacs). The imager,...

Foot melanoma is deadliest skin cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- As Americans become more diligent in donning hats and smearing on sunscreen to protect their heads, shoulders, and backs from the growing threat of malignant melanoma, they are overlooking the most...

Skin cancer responsible for high costs, morbidity in Australia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers from the Royal Prince Alfred Hospital report that skin cancer continues to be responsible for high medical costs and morbidity in Australia. W.H. Mccarthy and colleagues wrote,...

Test for diagnosing spread of melanoma can spare second operation.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A rapid test that can be performed during surgery to determine if melanoma has spread to lymph nodes has been developed at the Medical College of Wisconsin (MCW). The reagent making this possible...

Tyramide-based tyrosinase assay can improve diagnosis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- A tyramide-based tyrosinase assay can facilitate the diagnosis of melanoma. "Fine-needle aspiration (FNA) has been used as a fast, minimally invasive, and reliable method for the evaluation of...

Researchers map structure of anticancer molecule.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Scientists at Emory University, in collaboration with researchers at three national laboratories, have solved the structural puzzle of how an emerging class of promising cancer drugs works to halt cell...

Research group launched to accelerate drug development for blood cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The Multiple Myeloma Research Consortium (MMRC), a first-of-its kind nonprofit organization that integrates four leading cancer research institutions, has joined academic institutions through both...

Gefitinib does not improve survival in non-small cell lung cancer study patients.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers from the Netherlands reported that gefitinib treatment in non-small cell lung cancer failed to improve survival in study patients. "Gefitinib (Iressa) is a novel targeted therapy that...

Chemotherapy, ORT do not prevent CNS progression in ocular lymphoma study.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers from the U.S. reported that chemotherapy and/or ocular radiotherapy failed to prevent central nervous system (CNS) progression in study patients with primary ocular lymphoma; however,...

Cyclooxygenase 2 is an important regulator of lung cancer pathogenesis.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cyclooxygenase 2 is an important regulator of lung cancer pathogenesis. According to published research from the United States, "preclinical studies suggest that cyclooxygenase (COX)-2 may be...

L1-based diagnosis, prognosis may improve ovarian, endometrial cancer management.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers from Israel found that L1-based diagnosis and prognosis in ovarian and endometrial carcinomas may improve disease management. M. Fogel and colleagues wrote, "The L1 molecule has emerged...

Absence of chromosomal aberrations may predict favorable clinical outcome.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Genetic studies reveal that chromosomal imbalances may predict survival in women with ovarian cancer. "Ovarian cancer is the leading cause of death among patients with gynecological cancers, but...

Biotechnology company selects contract manufacturer for therapeutic antibody.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Morphotek Inc. has entered into an agreement for Baxter Healthcare Corporation to support the development and manufacture of its lead targeted cancer therapeutic antibody, MORAb-003, which is being...

Elevated levels of EphA2 protein may signal progression of ovarian cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced results showing that elevated levels of EphA2 frequently contribute to ovarian cancer progression and that high levels of this protein may relate to decreased patient...

Primary infertility due to endometriosis found to be cancer risk factor.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Previous studies have shown that a diagnosis of infertility significantly increases a woman's odds of developing ovarian cancer. A new retrospective analysis finds that the risk is related to the...

Triplex-forming oligonucleotide curtails the oncogene Ki-ras.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Triplex-forming oligonucleotide curtails the oncogene Ki-ras. According to published research from Italy, "the Ki-ras gene is frequently mutated and/or overexpressed in human cancer. Since it is...

Medical device company names new chief financial officer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Endocare Inc. announced that Michael R. Rodriguez has been named chief financial officer (CFO) and senior vice president, finance. Rodriguez, who will report directly to Endocare's chairman and...

MICs shed light on prostate cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The body's immune system has built in antitumor mechanisms. For cancers to form, one of the molecular steps that must occur is for the tumor cells to develop the means to avoid being attacked by this...

Radiation plus short-term hormone drugs improve prostate cancer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Men with prostate cancer that doesn't appear to have spread have better survival chances when they get short-term hormone treatment along with standard radiation, rather than radiation alone, a small...

Pharmaceutical company receives fast-track review for renal cell cancer treatment.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Pharmaceutical giant Wyeth has won fast-track review status from federal regulators for its drug temsirolimus, used to treat advanced renal cell carcinoma. Wyeth is seeking U.S. Food and Drug...

Melanoma incidence increased with no change in commensurate mortality.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The incidence of melanoma has increased with no change in commensurate mortality. "Melanoma incidence has increased dramatically over the last decades in most industrial countries, mainly as a...

Age 50 or older independent risk factor for HSCT treatment-related mortality.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Age 50 or older is an independent risk factor for hematopoietic stem cell transplantation treatment-related mortality. "Allogeneic hematopoietic stem cell transplantation (HSCT) has been performed...

Cytogenetics independent predictor of relapse/treatment failure in AML.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Cytogenetics is an independent predictor of relapse/treatment failure in acute myeloid leukemia patients. According to a study from Japan, "On the basis of transplantation data from the Japan...

High-dose chemotherapy with ASCT beneficial for bone and soft-tissue sarcomas.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- High-dose chemotherapy with allogeneic stem cell transplantation may be beneficial for bone and soft-tissue sarcomas. According to a study from Germany, "The role of high-dose chemotherapy (HDCT)...

WT1 gene transcript assay predicts relapse in acute leukemia after SCT.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The WT1 gene transcript assay predicts relapse in acute leukemia after allogeneic stem cell transplantation. According to recent research published in the journal Leukemia and Lymphoma, "The WT1...

Ultrasound screening reveals tumors not detected manually in infertile men.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Researchers at the urology clinic affiliated with the Sackler School of Medicine at Tel Aviv University in Israel have found that the majority of testicular tumors identified in the course of an...

Transparent microballoon dissection can improve surgical outcome.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Transparent microballoon dissection can improve the outcome of surgical brain tumor removal. "In spite of maximal microsurgical efforts, perilesional neural tissue can be injured by surgical...

Molecular markers available for detection and progression of prostate cancer.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Molecular markers are available for the detection and progression of prostate cancer. "Carcinoma of the prostate is the second leading cause of male cancer-related death in the United States....

Pegulated liposomal doxorubicin improves chemoradiation efficacy.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Pegulated liposomal doxorubicin (PLDH) can improve the efficacy of chemoradiation treatment for squamous cell carcinoma patients. Oncologists in Greece conducted a "phase I study of concurrent...

Positive data presented from phase I trial of EM-1421 in refractory cancer.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Erimos Pharmaceuticals announced that the results of an open-label, phase I, dose escalation study of intralesional injection of EM-1421 in head and neck cancer was presented by Terry A. Day, MD, at...

ED diagnoses sites of infection in cancer patients with neutropenia, fever.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- A study from the University of Pennsylvania Hospital showed that focal sites of infection in patients with fever and chemotherapy-induced neutropenia diagnosed in the emergency room were consistent...

Mode rate doses of corticosteroids increase invasive aspergillosis risk in ASCT.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Mode rate doses of corticosteroids increase the risk of developing invasive aspergillosis after allogeneic stem cell transplant. "The majority of invasive aspergillosis (IA) in allogeneic stem...